October 22 - 23, 2018
The Westin Princeton at Forrestal Village, NJ
Contact Us: 1.888.482.6012
Is Your Company Speaking at ProcureCon Pharma ? Save an Extra 20 % Off Your Ticket With Code: PCPSPKR
Vice President, Global Procurement
Pfizer Global Supply & Global Operations
Ron leads a global team responsible for procurement for Pfizer’s Global Supply and Global Operations divisions. His scope covers Pfizer’s production materials and contact manufacturing, supply chain providers, integrated facilities management, capital, energy and services expenditures. This includes strategic and operational procurement for 62 internal manufacturing sites, ~300 virtual supply sites, over 10,000 providers of goods and services, and administrative and R＆D facilities. His teams proposition is to drive a competitive advantage for the business through solutions and optimizing value delivery from the supplier base. This includes financial benefits, risk management, and supply base excellence, without compromise to quality and compliance.
Ron is a member of Pfizer’s Global Supply Executive Team. He serves on Pfizer’s Global Women's Council, Pfizer's Business Continuity, Supply Chain Security, Inventory, Global Recovery and Corporate Environmental Sustainability Steering Teams, and its Serialization Governance team. He's a member and previous chair of the Drug, Chemical and Associated Technologies (DCAT) Association's Supply Management Committee, and served two terms on DCAT's Executive Committee as Pharmaceutical Segment Vice President.
The majority of Ron’s two decades of pharmaceutical industry experience has been spent focused on manufacturing and global supply, with additional time spent in Clinical R&D, and supporting commercial and corporate needs. He previously held procurement responsibility for Pfizer’s Established Products and Emerging Markets operating units, and its Consumer Healthcare business. He joined Pfizer through Wyeth-Ayerst in 1996, and led sourcing teams in the areas of packaging, clinical research, facilities, corporate services, and marketing ＆ sales. Prior to Pfizer, Ron worked in the consumer goods industry, and had responsibilities for supplier quality management, procurement, and package engineering. He began his career as an engineer with a defense industry firm providing supply chain solutions to the US Navy.
Ron has a B.S. in Packaging from Michigan State University, and an MBA from The Pennsylvania State University.
Chief Procurement Officer
Dapo is the Chief Procurement Officer for AstraZeneca, where she is accountable for the external spend and supplier base across the end to end value chain. Dapo has spent her entire career in pharma and has a broad business background, having held a variety of senior leadership roles in Supply chain, Site Operations and Strategic Marketing.
Head of Procurement & Global Biotech
Sean Cumbie assumed the role as Head of Global Procurement, Biotech Units based out of the AZ/MedImmune campus in Gaithersburg, Maryland, in March 2015. As a member of the Global Procurement Leadership Team, Sean reports to Dapo Ajayi, CPO, and leads the early R&D science units and global FM procurement teams located in Gaithersburg, MD; Boston, MA; Cambridge & Manchester, UK; Gothenburg & Stockholm, Sweden; and Shanghai, China. Prior to joining AstraZeneca, Sean was VP of Global Supply Chain Management for QIAGEN based out of Zurich where he was responsible for global supply chain operations including sales & operational planning, forecasting, inventory management, distribution, transportation, and trade compliance. Before joining QIAGEN, Sean developed and led the MedImmune procurement team before its integration into AstraZeneca. Sean received his MBA and Bachelor of Mechanical Engineering from Georgia Tech (Atlanta, Georgia, USA) and resides in Northern Virginia.
Head of Strategic Business Services: Senior Director
Daiichi Sankyo Inc.
Senior Director of Global Procurement
As Senior Director of Global Procurement at Pfizer, James Tornos, PhD, MCIPS, CPSM has responsibility for all aspects of non-clinical R&D goods and services procurement, including categories such as Discovery Sciences Outsourcing, Toxicology & Lab Models, Capital Equipment & Servicing, Research Supplies, API, Drug Product, Clinical Packaging and Analytical Services. James’s team’s responsibilities include developing outsourcing strategies, executing strategic sourcing, category management, contract negotiations, and supplier relationship management. James has worked for Pfizer for 11 years, both in the UK and USA and previously at AstraZeneca. James graduated with a Bachelor of Science and a PhD in Chemistry and spent 5 years as a process development chemist at AstraZeneca, prior to moving into an outsourcing and procurement role. James lives in Madison, Connecticut with his wife and two sons.
AVP, Global Lead for Research & Development Sourcing & Procurement
Merck & Co., Inc.
Executive Director, Head of Global Strategic Sourcing
Ahmet Karacaoglu is the Head of Global Strategic Sourcing at Alexion Pharmaceuticals. In his role, he is leading procurement’s transformation into a strategic function and developing category management strategies for a total global spend of $1.8B. Prior to joining Alexion, Ahmet was the Head of Procurement at Noven Pharmaceuticals, Inc. where he built the Strategic Sourcing function and organization from the ground up. He was responsible for the procurement function and developing strategic partnerships to achieve both commercial synergies and competitive advantage. Ahmet and his team developed category-specific sourcing strategies and served as lead negotiators for enterprise-wide spend. Prior to joining Noven, Ahmet served as the Global Director of Procurement for Indirect at Shire Pharmaceuticals, where he oversaw a global spend of approximately $1B/yr. He has over 15 years of experience in strategic sourcing and supplier management in both direct and indirect categories at a global level. Ahmet is experienced at transforming decentralized procurement organizations into globally-connected, locally-wired business functions that drive performance through robust sourcing processes and demand management. He is well-regarded as a strategist and change agent who finds innovative solutions to business problems and challenges. He holds a BS in Economics from Istanbul University and an MBA in Finance and Information Systems from Drexel University.
Vice President & Head of Global Procurement, Scientific & Clinical,
Senior Director of Purchasing
Global Procurement Business Partner for the US Business Unit
Greg Fly is the Head of Vaccines Procurement for Takeda Pharmaceuticals based in Cambridge, MA supporting Takeda’s Vaccine Business Unit globally. His role includes business partnering with the Vaccine Leadership Team ensuring close collaboration and alignment between Global Procurement and the business. Prior to joining Takeda in 2015, Greg spent 13 years with Merck & Co. where he supported their Vaccines and Biologics Research Laboratories as a Biochemical Engineer before moving into R&D Procurement. Greg also led the Procurement organization for Secant Medical, a Biomedical Textile manufacturer. He has held various roles within R&D Procurement and has over 17 years of leadership experience in Procurement and Operations.
Head of Integrated Procurement Solutions
Dana Small is a Sourcing Manager at BioMarin Pharmaceutical supporting Global Commercial Operations. She has worked within the Pharmaceutical/Biotech industry for almost 15 years and filled a wide range of support functions during her 10+ years within finance. Her time in Strategic Sourcing has been spent on a multitude of indirect categories that depended on strategic thought partnership, data driven analytics, and category management to produce hard dollar / P&L savings enterprise wide.
Head of Prof Services, US. Commercial Services, Global Pharma Procurement
Jennifer Sadr leads a team that manages the professional services work within the US Commercial organization, spanning various categories: Consulting, Marketing Insights, Data, Training, Meetings and Events and Patient Access Services. She started her career in process development more than 15 years ago at Wyeth and joined Genentech in March 2005. She has spent the majority of her career working with contract manufacturing teams helping to manage their outsourced manufacturing processes. Throughout her professional career, she has had the opportunity to negotiate global projects across the pharmaceutical supply chain. She has been successful in collaborating globally and cross-functionally with businesses and suppliers to find innovative and sustainable solutions to business challenges. Jennifer graduated from University of Delaware with a BS in Chemical Engineering and currently resides in San Francisco, California.
Director, R&D Sourcing & Procurement
Merck & Co., Inc.
Adam is responsible for managing the research services spend for the Discovery Sciences area of Merck Research Laboratories (MRL). He is responsible for developing world class procurement strategies as well as provide overall category management for a very diverse group of activities covering Chemistry, Pharmacology, Translational Medicine, and Biologics & Vaccines. Adam previously worked in Direct Materials Procurement where he managed categories in the Chemicals, Vaccine, and Biologics space. Adam also managed categories in Marketing and HR services and worked in site roles at the Arecibo, Puerto Rico and West Point, PA manufacturing plants. Outside of Merck Adam has worked in business development as well as engineering in the aerospace industry.
Director, Development And Sourcing, Discovery and Product Development
Teva Global R&D
Vincent Djuhadi, MS, MBA has been part of Development and Sourcing Lead at Teva since 2011. In collaborations with Global Procurement in Israel, Vincent supports the Discovery and Product Development, a division of Teva Global R&D, in the identification, selection, and partnerships/relationship development and management of CDMO/CRO as well as key Suppliers/Vendors globally. In addition, in collaborations with Quality, Regulatory, Marketing, and Supply Chain, Vincent is also responsible for leading and managing a number major CMO globally in all aspects of CMC related to registration, production, and supply of APIs used in several key commercial products.
Prior to Teva, Vincent has worked for a number of pharmaceutical companies in various capacities including Technical Operations, Procurement, Head of Manufacturing, Process and Product Development, and Quality for Cephalon Inc., Schering Plough, and Johnson & Johnson.
Director – MedImmune Procurement Business Partner,
Mark Davis the business partner to AstraZenca’s MedImmune Biologics division. He has broad international and cultural experience in the pharmaceutical sector. His background across both organic chemistry and business has led to equal experiences in technical development and strategic procurement roles. Mark is passionate about solving unique problems, embracing disruption and innovative breakthroughs at the cross-roads of business and science.
Director of Supplier Relationship Management
Steve has been part of the Supplier Relationship Management team for Shire’s Small Molecule focused Operating Unit since the role was first established in 2008. His experience includes a number of fast paced growth oriented companies and spans finance, operations, business development and consulting. This multi-faceted business experience has formed the basis for his business strategist and coach approach to the Supplier Relationship Management role.
Senior Director of Pharmaceutical Development, Manufacturing & Quality
Valdas Jurkauskas, PhD, is the Senior Director of Pharmaceutical Development, Manufacturing and Quality at Corbus Pharmaceuticals, where he is responsible for all CMC activities and supply chain. Dr. Jurkauskas’ expertise is in process development, drug substance and drug product manufacturing, commercial process validation, and regulatory filings. Prior to joining Corbus, Dr. Jurkauskas led Technical Operations at STA Pharmaceuticals Co., Ltd., a WuXi AppTec Company, and Active Pharmaceutical Ingredient Process Development at Cubist Pharmaceuticals, which was acquired by Merck & Co., Inc.. He was a member of Chemical Development at Vertex Pharmaceuticals. Dr. Jurkauskas earned his PhD degree in Organic Chemistry at the Massachusetts Institute of Technology under the guidance of Professor Stephen L. Buchwald and his Bachelor of Science in Chemistry at the University of Toronto.
Director, Strategic Sourcing, Professional Services & IT
Alexion Pharmaceuticals, Inc.
Lisa is a senior leader in sourcing and procurement with expertise in strategic planning, operational execution, stakeholder partnering and supplier relationship management. Lisa’s experience comes from her time in a top tier consultancy, public accounting, and industry roles with Fortune 100 and 500 finance and pharmaceutical companies. In these roles, she grew a deep appreciation for what is needed to successfully build and lead cross-functional teams in negotiations, outsourcing, policy development, process improvement, and change management efforts. Lisa attended the University of Texas at Austin, receiving an MBA in Business, as well as the University of Houston Honors College where she obtained her BBA in Accounting. In her personal time, Lisa enjoys expanding her education, health and fitness activities, and spending time with her husband and two daughters.
Procurement Management | Global Strategic Sourcing | Category Partner | Supplier Management
University of South Florida
Associate Professor of Supply Chain Management
Rutgers Business School
Arash Azadegan (PhD, W.P. Carey School of Business, Arizona State University) is an Associate Professor at Rutgers Business School and the Director of Supply Chain Disruption Research Laboratory (SCDrl). Dr. Azadegan has an active stream of research focused on humanitarian supply chains and crisis management. Among his ongoing projects, he is working on research that explores the nature of trust and reciprocity among inter-sectoral collaborations during humanitarian relief. A related project focuses on detailing the network structure and nature of relationships among NGOs during hurricane Sandy. A second stream of project focuses on the influence and effectiveness of leadership traits in managing large scale disasters. Dr. Azadegan has shared his research findings in numerous national and international venues, including Columbia University’s National Center for Disaster Preparedness, Transportation Research Board in Washington DC and at multiple Universities in China. He has close collaborative relationship with NYU’s International Center for Enterprise Preparedness (INTERCEP) which is dedicated to regional and organizational resilience. Dr. Azadegan’s work is published in several top operations, supply chain and management journals including the Journal of Operations Management, Journal of Supply Chain Management, Production and Operations Management, Journal, Journal of Business Ethics and the Decision Sciences Journal among others. Dr. Azadegan is an active member of Production Operations Management Society (POMS) and Decision Sciences Institute (DSI) and serves on the executive board of the Council of Supply Chain Management Professionals – New York.
University of South Florida
Iana Shaheen is a 2nd year Ph.D. student at the University of South Florida. Her key research interests include supply chain disruptions, leadership, sustainability, and disaster relief management. She has been involved with several projects regarding product returns, leadership, and transportation logistics. Iana’s research is accepted for presentation at several major Conferences, including Production and Operations Management Society, Academy of Management, Academy of Marketing Science, LogiPharma, and Decision Sciences in 2017. In collaboration with Dr. Arash Azadegan, Iana has a proceeding at Academy of Management titled “Leadership in the Face of Major Supply Chain Disruptions: Differentiating between Baseline and Contextual Traits.” She currently has an article under review at Journal of Supply Chain Management.
Brian is an engineer/MBA with extensive experience in the pharmaceutical and biotech industry. Prior to joining Scientist.com he was an internal consultant driving strategic procurement projects at AstraZeneca, including the AstraZeneca Innovation Marketplace (AIM). He developed the Strategic Sourcing function at Human Genome Sciences as the company launched its first commercial product. He led several successful international projects as a process engineer at Merck & Co., and he has taught Supply Chain Management as an Adjunct Professor at Mount St Mary’s University. At Scientist.com he is focused on collaborating with industry partners to break down barriers to external innovation. Brian has a BS in Chemical Engineering, an MBA from Penn State and is currently completing a MS in Biotechnology at Johns Hopkins.
Founder & CEO
Dr. Elizabeth Iorns is the Founder & CEO of Science Exchange, the Co-Director of the Reproducibility Initiative, and is a part-time partner at Y Combinator. Elizabeth has a Ph.D. in Cancer Biology from the Institute of Cancer Research (UK), and before starting Science Exchange in 2011 was an Assistant Professor at the University of Miami (where she remains an Adjunct Professor). Elizabeth has received a range of honors and recognition, including the Kauffman Foundation Emerging Entrepreneur Award, one of Nature Magazine’s ‘Ten People Who Mattered’, and one of WIRED’s '50 Women Who Are Changing The World'. Elizabeth is focused on the development of innovative models to promote the quality and efficiency of scientific research.
Founder & CEO
Stephany Lapierre is the founder and CEO of tealbook. Prior to tealbook, Stephany spent 10 years building a successful strategic sourcing consulting firm and helping Fortune 500 and emerging companies efficiently find and identify qualified global suppliers able to meet their demand. Based on her experience, she built and launched tealbook in 2014, a cloud-based platform that allows enterprises to take disparate sources of data and aggregate them, reducing process and user friction through accelerated access to qualified incumbent and trusted new suppliers.
Stephany is a regular guest on popular procurement podcasts and blogs such as the Art of Procurement, Buyers Meeting Point, and Procurious. She speaks at conferences on procurement's ability to positively impact their organization through access to collective intelligence and accelerated supplier discovery. She has been recognized as an influencer by PharmaVOICE 100, was selected as a 2017 Provider Pro to Know by Supply & Demand Chain Magazine, and has won several awards for her innovative approach to aggregating trusted supplier intelligence.
Shreyas is a Principal with ZS in the San Francisco office. He has been a consultant in the healthcare industry for 12+ years. His focus is on building commercial organizations, specialty therapeutics and analytics for decision making, and he has lead a variety of sales and marketing engagements with emerging and established biopharmaceutical companies. Shreyas also leads the procurement relationship function at ZS Associates, working with multiple companies on building sustainable partnerships and driving innovation. Shreyas holds an MBA in Marketing and Strategy from Haas School of Business at University of California at Berkeley. He also has an MS in Management Information Systems from Texas A&M University and a BS in Computer Engineering.
Director of National Accounts
Tripp is an experienced sales professional within the manufacturing, supply and distribution industry with a successful sales background in business/contract analysis, vendor and account management, customer service and contracting and procurement principals. For CoreTrust, Tripp’s focus is on indirect supply chain procurement for products and services within the manufacturing vertical market. Prior to this role with CoreTrust, Tripp worked to build custom solution offerings as part of the Purchased Services team at HealthTrust. He is a graduate of the University of Tennessee in Knoxville with a bachelor’s degree in General Business and Economics.
AVP – Business Development
Brian is the AVP of Business Development for CoreTrust, a leading sourcing agency with approximately 1,650 members and 150 contracts across multiple indirect spend categories. Brian leads a team responsible for the firm’s key strategic relationships and new category development. Throughout his seven years at CoreTrust, Brian has created and served in a number of different roles of increasing responsibility, most recently as the Senior Director of Sales. Prior to joining CoreTrust, Brian was an Equity Research Associate specializing in Apparel Retailers & Wholesalers with SunTrust Robinson Humphrey. In that role, Brian was responsible for financial modeling/forecasting, developing trading ideas and strategies and creating research notes. Brian received his BA in Finance from Fairfield University in Fairfield, Conn. He is married with two children and lives in Nashville, Tenn.
Founder & CEO
Chris conceptualized and founded iSpecimen in response to the precision medicine movement and the growing demand for biospecimens by life science researchers. As CEO, he is responsible for the company’s growth, performance, and corporate direction. Under his leadership, iSpecimen has become a dominant player in research sample procurement, recently developing and launching the industry’s first and only true marketplace platform connecting researchers with healthcare providers and biorepositories.
Prior to launching iSpecimen, Chris served as Managing Director at Leerink Partners (formerly Leerink Swann), a leading healthcare and life science investment bank, where he managed the expansion and delivery of services and directed strategy to develop new healthcare data and information assets for the firm. At Leerink, Chris launched Health Insight Technologies, a healthcare informatics company that was spun out of the firm as Humedica and acquired by UnitedHealth Group in 2013.
Prior to Leerink, Chris was a co-founder and Managing Director of Boston Medical & Scientific Advisors, a healthcare investment research firm ultimately acquired by Leerink. He received both his Ph.D. in Immunology and his M.D. from Tufts University and completed his residency training, including a year as Chief Resident, in Pathology at Brigham & Women’s Hospital and Harvard Medical School.
Vishal Bhandari is a partner in A.T. Kearney’s Health Practice and co-leads the procurement transformation offering for the practice. With more than 18 years of consulting experience serving clients in North America, Europe, and Asia, Vishal’s expertise spans across the healthcare value chain and is primarily focused on life sciences manufacturing and retail pharmacy sectors; including mergers and acquisitions, supply chain strategy, and procurement transformation. Over the last decade, Vishal has worked with more than a dozen leading healthcare companies, helping CPOs redefine their procurement operating model, develop innovative category strategies for $200B+ in external spend and deliver $15B+ in EBIT impact. Vishal is a frequent contributor to Health publications and journals such as Chain Drug Review and Life Science Leader. He earned an M.B.A. from Kelley School of Business, Indiana University, and a Bachelor of Technology degree in engineering from NIT Kurukshetra, India. Vishal is based in A.T. Kearney’s Chicago office.
Partner, Life Science Practice Lead
Mr. Lightman heads ISG's Life Sciences practice. He advises clients on all aspects of the services lifecycle from initial strategy through design and build of governance organizations. As a qualified English attorney he initially focused on the transactional activities and still maintains deep SME knowledge relating to structuring and negotiation of contracts. His experience includes over 50 ISG engagements whose scope comprised ITO, BPO, FSO and KPO elements and has also assisted clients in developing enterprise vendor management functions. He has supported clients in over 10 countries and is based in New York City.
Vice President and Global Practice Lead, Life Sciences Solutions
Kelly Outsourcing and Consulting Group
Mark A. Lanfear is a 20-year veteran of the life sciences and consumer health industries. He defines himself as a productive-disruptor, futurist, and trend watcher. Mark has spent his time in the research and development halls of such well-known contributors as Pfizer, Roche and Abbott. A thought leader in talent management, Mark was recently cited in the best-selling book Lead the Work. He considers himself an avid Detroiter, his hometown, but has worked in regions from Mumbai to Mexico City and from Belgium to San Francisco Bay. In his current role as vice president and global practice lead, he excels at applying strategic models like Functional Service Provider (FSP), connecting STEM talent to opportunities in the shifting world of work. Mark leads the development of several market strategies to support the growth of human capital solutions in the life sciences industry for KellyOCG, the outsourcing and consulting group of workforce leader, Kelly Services®. A graduated from the University of Michigan, Mark is a board member of the Coalition on Temporary Shelter (COTS Detroit) where he chairs the fund-development committee. He is a member of the Detroit Athletic Club, the Drug Information Association, the Association of Clinical Research Professionals and an educational member of the American Diabetes Association. In addition, Mark is a “scientific friend” to the Jalen Rose Leadership Academy. He has authored numerous industry articles including “Mapping the Workforce Genome” and made a guest appearance on the History Channel where he discussed the evolution of the drug development industry.
President & CEO
Professional Purchasing Partners
Dr. Joseph Richardson is an International Supply Chain Management Executive with demonstrated leadership in designing, developing and implementing effective sourcing, supply chain and procurement strategies (direct and indirect) that address global business issues. His international experience, with a variety of companies, helped him to recognize the political, cultural and technical challenges that affect business relationships, internally, externally and internationally. He is a visionary who integrates theory and practice in creating and executing innovative approaches and methods to accomplish complex business objectives. He is considered an International Subject Matter Expert (SME) in Supply Chain and Organizational Behavior. Joseph has received numerous awards for his professional services and serves on several Advisory Boards.